<DOC>
	<DOCNO>NCT02008838</DOCNO>
	<brief_summary>To evaluate effect synbiotic supplementation insulin resistance , lipid profile subject metabolic syndrome , randomize , double-blind , placebo-controlled pilot study , 38 subject metabolic syndrome supplement either synbiotic placebo capsule twice/day 28 week . Both synbiotic ( G1 ) placebo ( G2 ) group advise follow energy balance diet physical activity recommendation . Parameters related metabolic syndrome insulin resistance measure every 7 week study course .</brief_summary>
	<brief_title>Effects Synbiotic Supplementation Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>18 year age old three follow five feature : Increased waist circumference ( ≥102 cm men ≥88 cm woman ) , elevate TG ( ≥150 mg/dl ) , reduce HDLC ( ≤40 mg/dl men ≤50 mg/dl woman ) , elevate blood pressure ( ≥130/85 mm Hg treatment hypertension ) elevate glucose ( ≥100 mg/dl ) , accord National Cholesterol Education Program Adult Treatment Panel III report BMI : 25≥ BMI ≥ 40 Use antibiotic 2 week recruitment study A history alcohol consumption Pregnancy &amp; Breast feeding , Professional athelets A history Cardiovascular disease , Pulmonary disease , Renal disease &amp; Celiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>